Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I did fill some more @.303 (average now .306-ish)
,,,,,,,YOU’RE FUNNY! WARRANTS UP 60% AND NDRA BASICALLY NO CHANGE…JUST PLODDING ALONG. NO WORRIES HERE MATE
HOPE YOU DO GET YOUR FILL!
-CHEERS
Those selling will burn soon mark it $$$
"According to Sagient Research Systems, H.C. Wainwright's team is ranked as the #1 Placement Agent in terms of aggregate PIPE and RD transactions cumulatively since 1998."
NDRA
And price keeps going down. Trash
HC Wainwright is a disgrace..
1 million shares traded in the first 3.5 minutes of trading
Agreed, got my buy orders in below .29
Monday will be interesting locked and loaded $$$
Average vol.6.7 million...75.4 million traded friday...Interesting..nice money flow here..
,,,,,,,LOAD’EM .88 is the trigger
Wondering if the offering filed on the 30th of last month has something to do with the drop on Friday... Watching
,,,,,,, NDRA HAS TO GET WARRANTS UP…IN—1MONTH
Now .03
TWO MAJOR PIECES OF NEWS…DUE NOW:#2
Adding limited confirmatory clinical data from a subset of ENDRA’s existing clinical evaluation sites, which is expected to be available in 2022.
"We are very encouraged with FDA’s feedback on our TAEUS System’s safety and performance data as well as their support of a De Novo pathway, which is well-suited to TAEUS’ low-to-moderate risk profile and ENDRA’s desired market claims for our novel technology. ENDRA believes it is now aligned with the FDA on the scope of the limited confirmatory clinical data, which is the primary remaining element needed for a De Novo submission. We are confident that a De Novo request is the strongest path to bring our TAEUS technology to the U.S. market. We believe this process should yield sustainable commercial advantages for our TAEUS platform
TWO MAJOR PIECES OF NEWS…DUE NOW:#1
In December 2020, ENDRA renewed its collaboration agreement with the GE Healthcare unit of the General Electric Company, extending the agreement's term by two years to December 2022.
MORE NEWS:
In a report released today, Vernon Bernardino from H.C. Wainwright reiterated a Buy rating on ENDRA Life Sciences, with a price target of $5.00. The company’s shares closed last Wednesday at $0.40, close to its 52-week low of $0.34.
,,,,,,,WEEEEEEE! YOU CANT CONVINCE ME….$1-$3 in 1MONTH IS NOT DOABLE
There is no loosing position $$$$
75M VOL…HUGE COVER OR SOMETHING BIG IS GOING ON BEHIND THE SCENES
I don’t know. All they have said is they are working on a partnership for another application for TAEUS. Could be GE could be someone else.
The next news should be…GE RIGHT???
This will run Monday load up $$$$$$$$ Mark it
,,,,,,,BUY THE WARRANTS!!!! EASY TRIPLE WHEN THIS GOES$$$$
.03 NDRAW
It’s cheap dont miss out price target $5
So this stock goes from .65 to .28 and people think this is a good thing? What am I missing here?
,,,,,,,Have a good weekend. Got my starter positions
Got warrants and the commons
Good to know ty!
New lows??
,,,,,,,I think,,I’ll add a few delicious 30’s
Warrants are in play -- nearly 150% of ENDRA's shares have already changed hands today.
NDRA
NDRAW
Well they have till then to move this up
The warrants were created with there first offering about 4 years ago they have a strike price of $6.25 approx and expire in May 2022.
that's not good considering the direction the stock is taking at the moment.
$20M money flow today and $5 price target. We know where this is going to go. End of story
They expire in 30-40 days.
52 week lows now??
,,,,,,,Yup I added warrants $NDRAW
WARRANTS up 174%+!!!! (However, it's a GAPPER!! Dangerous!!)
Followers
|
52
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1262
|
Created
|
10/24/18
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |